- BySeeking Alpha-
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Healthcare, Technology and Consumer Services sectors led shares higher. At the close in NYSE,...
Trxade (MEDS) +100%, Reneo Pharmaceuticals (RPHM) +13%, Aethlon Medical AEMD -28%, Ocugen OCGN -23%
The medical technology company Aethlon Medical, Inc. (AEMD), which is focused on addressing unmet needs in global health, has been in headlines for its lead product, Hemopurifier....
1. Aethlon Medical, Inc. (AEMD) Aethlon Medical (NASDAQ:AEMD) has been in an explosive trend, literally going from 75 cents around the first of Jan to 4.00 currently, but you can...
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.